Alkermes
Price & Volume
Stats
See moreOpen | $30.57 |
Previous Close | $30.65 |
Day Range | $30.50-$31.32 |
52W Range | $25.16-$36.45 |
Market Cap | $5B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $1.5B |
Revenue Growth (YoY) | -2.1% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $2.23 |
News
See moreYahoo Finance • 17 hours ago
Deutsche Bank’s ‘Conviction list’ for Q4: KO, SCHW, LLY and more
Yahoo Finance • 7 days ago
Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says
Yahoo Finance • 7 days ago
Alkermes upgraded at RBC Capital Markets ahead of key catalyst
Yahoo Finance • 7 days ago
CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls
About
CEO | Mr. Richard F. Pops |
Address | Connaught House, Dublin, Ireland, D04 C5Y6 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,800 |
